• Homepage
  • anti-ST6 (Alpha-N-Acetyl-Neuraminyl-2,3-beta-Galactosyl-1,3)-N-Acetylgalactosaminide alpha-2,6-Sialyltransferase 2 Antibodies

anti-ST6 (Alpha-N-Acetyl-Neuraminyl-2,3-beta-Galactosyl-1,3)-N-Acetylgalactosaminide alpha-2,6-Sialyltransferase 2 (ST6GALNAC2) Antibodies

ST6GALNAC2 belongs to a family of sialyltransferases that add sialic acids to the nonreducing ends of glycoconjugates. Additionally we are shipping ST6 (Alpha-N-Acetyl-Neuraminyl-2,3-beta-Galactosyl-1,3)-N-Acetylgalactosaminide alpha-2,6-Sialyltransferase 2 Proteins (11) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
ST6GALNAC2 10610 Q9UJ37
ST6GALNAC2 20446 P70277
ST6GALNAC2 303692  
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-ST6 (Alpha-N-Acetyl-Neuraminyl-2,3-beta-Galactosyl-1,3)-N-Acetylgalactosaminide alpha-2,6-Sialyltransferase 2 Antibodies at antibodies-online.com

Showing 10 out of 21 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Cow Rabbit Un-conjugated WB WB Suggested Anti-ST6GALNAC2 Antibody Titration: 0.2-1 ug/mlPositive Control: Human heart 100 μL Log in to see 2 to 3 Days
$289.00
Details
Dog Rabbit Un-conjugated WB Host: Rabbit Target Name: St6galnac2 Antibody Dilution: 1.0ug/ml Sample Type: Rat Liver 100 μL Log in to see 2 to 3 Days
$289.00
Details
Dog Rabbit Un-conjugated WB 50 μg Log in to see 11 to 14 Days
$551.83
Details
Human Rabbit Un-conjugated IHC, IHC (p), WB Western Blot: ST6GALNAC2 Antibody [NBP2-20494] - Sample (30 ug of whole cell lysate) A: 293T 10% SDS PAGE gel, diluted at 1:3000. Immunohistochemistry-Paraffin: ST6 Sialyltransferase 2/ST6GALNAC2 Antibody dilution: 1:250. 0.1 mL Log in to see 8 to 11 Days
$516.98
Details
Human Rabbit Un-conjugated ELISA, WB 50 μg Log in to see 2 to 3 Days
$446.88
Details
Human Rabbit Un-conjugated IHC, IHC (fro), IHC (p), WB Western Blot: ST6 Sialyltransferase 2/ST6GALNAC2 Antibody - Lane 1: Marker 250, 130, 100, 70, 55, 35, 25, 15, 10Lane 2: Human cell line SK-MEL-30 0.1 mL Log in to see 10 to 13 Days
$494.38
Details
Human Rabbit Un-conjugated WB   50 μg Log in to see 11 to 14 Days
$551.83
Details
Human Rabbit Un-conjugated WB ST6GALNAC2 antibody used at 1 ug/ml to detect target protein. 50 μg Log in to see 9 to 11 Days
$473.93
Details
Rat Rabbit Un-conjugated WB Western Blot: ST6 Sialyltransferase 2/ST6GALNAC2 Antibody [NBP1-98415] - Rat Liver Lysate 1.0ug/ml 100 μL Log in to see 8 to 11 Days
$488.73
Details
Human Mouse Un-conjugated ELISA, WB ST6GALNAC2 polyclonal antibody (A01), Lot # 060529JCS1 Western Blot analysis of ST6GALNAC2 expression in HeLa . Western Blot detection against Immunogen (38.21 KDa) . 50 μL Log in to see 11 to 12 Days
$305.71
Details

Top referenced anti-ST6 (Alpha-N-Acetyl-Neuraminyl-2,3-beta-Galactosyl-1,3)-N-Acetylgalactosaminide alpha-2,6-Sialyltransferase 2 Antibodies

  1. Human Polyclonal ST6GALNAC2 Primary Antibody for IHC, IHC (fro) - ABIN4356141 : Jia, Barclay, Roberts, Yen, Chan, Lam, Air, Peiris, Dell, Nicholls, Haslam: Glycomic characterization of respiratory tract tissues of ferrets: implications for its use in influenza virus infection studies. in The Journal of biological chemistry 2014 (PubMed)

More Antibodies against ST6 (Alpha-N-Acetyl-Neuraminyl-2,3-beta-Galactosyl-1,3)-N-Acetylgalactosaminide alpha-2,6-Sialyltransferase 2 Interaction Partners

Human ST6 (Alpha-N-Acetyl-Neuraminyl-2,3-beta-Galactosyl-1,3)-N-Acetylgalactosaminide alpha-2,6-Sialyltransferase 2 (ST6GALNAC2) interaction partners

  1. MicroRNAs miR-135b and miR-182 may reverse the resistance to 5-fluorouracil (5-FU) in colorectal cancer (CRC) cells by targeting ST6GALNAC2 via PI3K/AKT pathway, which render potential chemotherapy targets for the treatment of CRC.

  2. miR-182/-135b/ST6GALNAC2/PI3K/AKT axis could function as regulator of progression in colorectal cancer

  3. Study provides evidence that mutations in B3GNT2, B4GALT2, and ST6GALNAC2 underlie aberrant glycosylation, and contribute to the pathogenesis of molecular subsets of colon and other gastrointestinal malignancies.

  4. Results provide evidence that ST6GalNAcII activated the invasion in follicular thyroid cancer cells through regulating the activity of PI3K/Akt pathway.

  5. High expression level of ST6GalNAcII is associated with invasive phenotype of breast cancer.

  6. ST6GalNAc II might be participated in the glycosylation of Axl, and this Axl glycosylation may mediate the tumorigenicity, invasion, and distant metastasis of breast phyllodes tumor cells.

  7. Results identified the sialyltransferase ST6GalNAc2 as a novel breast cancer metastasis suppressor.

  8. Il-6 and Il-4 reduced galactosylation of the O-glycan substrate directly via decreased expression of the galactosyltransferase C1GalT1 and, indirectly, via increased expression of the sialyltransferase ST6GalNAc-II

  9. ST6GalNAc2 is a novel enzyme that regulates leukocyte adhesion under fluid shear

  10. Expression of the ST6-GalNAcII gene and activity of the CMP-NeuAc:GalNAc-IgA1 alpha2,6-sialyltransferase were higher in immunoglobulinA1-producing cell lines.

  11. the ADG haplotype in the ST6GALNAC2 gene is a functional regulatory variant that may contribute to the genetic susceptibility in a subset of patients in whom the desialylation of IgA1 molecules was the main causative pathogenesis of IgAN

  12. reduced sialylation of serum IgA1 may result from decreased expression of ST6GALNAC2.

  13. potential genetic interactions of C1GALT1 and ST6GALNAC2 variants influence IgA1 O-glycosylation, disease predisposition, and disease severity, and may contribute to the polygenic nature of IgA nephropathy

ST6 (Alpha-N-Acetyl-Neuraminyl-2,3-beta-Galactosyl-1,3)-N-Acetylgalactosaminide alpha-2,6-Sialyltransferase 2 (ST6GALNAC2) Antigen Profile

Protein Summary

ST6GALNAC2 belongs to a family of sialyltransferases that add sialic acids to the nonreducing ends of glycoconjugates. At the cell surface, these modifications have roles in cell-cell and cell-substrate interactions, bacterial adhesion, and protein targeting (Samyn-Petit et al., 2000

Gene names and symbols associated with ST6GALNAC2

  • ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 (ST6GALNAC2) antibody
  • ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 (St6galnac2) antibody
  • ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 (St6galnac2) antibody
  • II antibody
  • SAITL1 antibody
  • Siat7 antibody
  • Siat7b antibody
  • SIATL1 antibody
  • ST6GalNAc antibody
  • ST6GalNAII antibody
  • STHM antibody

Protein level used designations for ST6GALNAC2

(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl galactosaminide B , (alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl galactosaminide alpha-2,6-sialyltransferase , SIAT7-B , ST6GalNAc II , ST6GalNAcII , alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 , galNAc alpha-2,6-sialyltransferase II , sialyltransferase 7 ((alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl galactosaminide B , sialyltransferase 7 ((alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl galactosaminide alpha-2,6-sialyltransferase) B , sialyltransferase 7B , sialyltransferase-like 1 , sialyltransferase 7 , Gal-beta-1,3-GalNAc alpha-2,6-sialyltransferase , alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase II , sialyltransferase 7 ((alpha-N-acetylneuraminyl 2,3-beta-galactosyl-1,3)-N-acetyl galactosaminde alpha-2,6-sialyltransferase) B , alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase II () , Gal beta 1,3 GalNAc - specific GalNAc alpha 2,6-sialyltransferase , gal-beta-1,3-GalNAc alpha-2,6-sialyltransferase

GENE ID SPECIES
10610 Homo sapiens
100049005 Canis lupus familiaris
511690 Bos taurus
20446 Mus musculus
303692 Rattus norvegicus
396159 Gallus gallus
Selected quality suppliers for anti-ST6 (Alpha-N-Acetyl-Neuraminyl-2,3-beta-Galactosyl-1,3)-N-Acetylgalactosaminide alpha-2,6-Sialyltransferase 2 (ST6GALNAC2) Antibodies
Did you look for something else?